-
1.
Gupta S, et al. Acute kidney injury in patients treated with immune checkpoint inhibitors. J Immunother Cancer 2021; 9:e003467. doi: 10.1136/jitc-2021-003467
-
2.
Seethapathy H, et al. The incidence, causes, and risk factors of acute kidney injury in patients receiving immune checkpoint inhibitors. Clin J Am Soc Nephrol 2019; 14:1692–1700. doi: 10.2215/CJN.00990119
-
3.
Seethapathy H, et al. Immune checkpoint inhibitors and kidney toxicity: Advances in diagnosis and management. Kidney Med 2021; 3:1074–1081. doi: 10.1016/j.xkme.2021.08.008
-
4.
Farooqui N, et al. Cytokines and immune cell phenotype in acute kidney injury associated with immune checkpoint inhibitors. Kidney Int Rep [published online ahead of print December 5, 2022]. https://www.sciencedirect.com/science/article/pii/S2468024922018836
-
5.
Moledina DG, et al. Urine TNF-α and IL-9 for clinical diagnosis of acute interstitial nephritis. JCI Insight 2019; 4:e127456. doi: 10.1172/jci.insight.127456
-
6.
Isik B, et al. Biomarkers, clinical features, and rechallenge for immune checkpoint inhibitor renal immune-related adverse events. Kidney Int Rep 2021; 6:1022–1031. doi: 10.1016/j.ekir.2021.01.013
-
7.
Singh S, et al. Tertiary lymphoid structure signatures are associated with immune checkpoint inhibitor related acute interstitial nephritis. JCI Insight [published online ahead of print December 1, 2022]. doi: 10.1172/jci.insight.165108; https://insight.jci.org/articles/view/165108
Use of Biomarkers in Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: Is Prime Time Fast Approaching?
© 2021 American Society of Nephrology | All Rights Reserved
Powered by: PubFactory